Tyra Biosciences, Inc.
TYRA
$25.38
$0.361.42%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 34.14M | 31.48M | 29.83M | 29.07M | 27.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 160.46M | 142.91M | 132.76M | 125.99M | 121.65M |
| Operating Income | -160.46M | -142.91M | -132.76M | -125.99M | -121.65M |
| Income Before Tax | -148.57M | -131.11M | -119.95M | -111.68M | -105.83M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -148.57 | -131.11 | -119.95 | -111.68 | -105.83 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -148.57M | -131.11M | -119.95M | -111.68M | -105.83M |
| EBIT | -160.46M | -142.91M | -132.76M | -125.99M | -121.65M |
| EBITDA | -159.92M | -142.37M | -132.22M | -125.43M | -121.10M |
| EPS Basic | -2.39 | -2.17 | -2.01 | -1.88 | -1.79 |
| Normalized Basic EPS | -1.50 | -1.36 | -1.26 | -1.17 | -1.12 |
| EPS Diluted | -2.39 | -2.17 | -2.01 | -1.88 | -1.79 |
| Normalized Diluted EPS | -1.50 | -1.36 | -1.26 | -1.17 | -1.12 |
| Average Basic Shares Outstanding | 247.24M | 240.80M | 238.39M | 237.62M | 236.82M |
| Average Diluted Shares Outstanding | 247.24M | 240.80M | 238.39M | 237.62M | 236.82M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |